Cited by 153Psychedelics and Drug StudiesNeurotransmitter Receptor Influence on BehaviorForensic Toxicology and Drug Analysis

The DOI matches its Crossref record; 53 of the 58 references it cites were found in a registry or an index.

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

Tancer, Manuel, Johanson, Chris-Ellyn·2003·Drug and Alcohol Dependence

DOI 10.1016/s0376-8716(03)00172-8

Open this paper in CoChat — free account

Abstract

3,4-methylenedioxymethamphetamine (MDMA) is a widely used drug of abuse chemically related to both the amphetamines and mescaline. Laboratory animal studies have shown that MDMA is a potent re-uptake inhibitor and releaser of dopamine and serotonin. Although the subjective and physiological effects of MDMA have been compared to d-amphetamine in humans, no direct comparison with a serotonin releasing agent has been reported and reinforcing effects have not been evaluated. In this paper we report a direct comparison of the reinforcing, subjective, and physiological effects of MDMA (1 and 2 mg/kg) to d-amphetamine (10 and 20 mg), to metachlorophenylpiperazine (mCPP--a serotonin releasing agent (0.5 and 0.75 mg/kg)), and to placebo using a within-subject design in 12 volunteers with moderate MDMA experience. Both the high dose of d-amphetamine and MDMA showed significant reinforcing effects as indicated by high cross-over values on the multiple choice procedure compared to all other treatments. All three drugs showed dose-dependent changes in subjective effects whereas physiological effects were most pronounced for MDMA with almost no changes seen with mCPP. The subjective effects of MDMA were similar both to those of mCPP and d-amphetamine, suggesting that both dopamine and serotonin systems are involved in mediating these effects. In contrast, only the dopaminergic agents, d-amphetamine and MDMA, had reinforcing effects.

Integrity signals

Registry

Crossref · 10.1016/s0376-8716(03)00172-8

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man
Martin, W. R., Sloan, J. W., SAPIRA, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 945
Methods of Assessing the Reinforcing Properties of Abused Drugs
Bozarth, M. A. (1987) · Springer eBooks · doi:10.1007/978-1-4612-4812-5 · Cited by 693
The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.
Kalant, H. (2001) · Europe PMC (PubMed Central) · Cited by 604
Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers
Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00013-x · Cited by 448
Cardiovascular and Neuroendocrine Effects and Pharmacokinetics of 3,4-Methylenedioxymethamphetamine in Humans
Mas, M., Farré, M., de la Torre, R., Roset, P. N., Segura, J. O., & Camí, J. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34877-3 · Cited by 362
Gender differences in the subjective effects of MDMA
Liechti, M. E., Gamma, A., & Vollenweider, F. X. (2001) · Psychopharmacology · doi:10.1007/s002130000648 · Cited by 360
Untitled work
(1988) · PubMed · Cited by 313
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Gouzoulis‐Mayfrank, E. (2000) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.719 · Cited by 306
m-Chlorophenylpiperazine as a probe of serotonin function
Kahn, R. S., & Wetzler, S. E. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90184-n · Cited by 293

Show all 58 references

Sorted by citations

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar‐Klosinski, B., Michel, Y., Brewerton, T. D., & Doblin, R. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112456611 · Cited by 399
Clinical toxicology of newer recreational drugs
Hill, S. L., & Thomas, S. H. L. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.615318 · Cited by 288
Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview
Capela, J. P., Carmo, H., Remião, F., Bastos, M. D. L., Meisel, A., & Carvalho, F. D. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8064-1 · Cited by 294
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
Baumann, M. H., Wang, X., & Rothman, R. B. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0322-6 · Cited by 258
Is Ecstasy an “Empathogen”? Effects of +/- 3,4-Methylenedioxymethamphetamine on Prosocial Feelings and Identification of Emotional States in Others
Bedi, G., Hyman, D., & de Wit, H. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.003 · Cited by 247
Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects
Holze, F., Vizeli, P., Müller, F., Ley, L., Duerig, R., Varghese, N., Eckert, A., Borgwardt, S., & Liechti, M. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0569-3 · Cited by 247
3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
Marcela Ot’alora, G., Grigsby, J., Poulter, B., Derveer, J. W. V., Giron, S. G., Jerome, L., Feduccia, A. A., Hamilton, S., Yazar‐Klosinski, B., Emerson, A., et al. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118806297 · Cited by 252
A review of the acute subjective effects of MDMA/ecstasy
Baylen, C. A., & Rosenberg, H. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01423.x · Cited by 214
Effects of MDMA on sociability and neural response to social threat and social reward
Bedi, G., Phan, K. L., Angstadt, M., & de Wit, H. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1635-z · Cited by 206
Pharmacological treatment of anxiety disorders: Current treatments and future directions
Farach, F. J., Pruitt, L. D., Jun, J. J., Jerud, A. B., Zoellner, L. A., & Roy‐Byrne, P. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.07.009 · Cited by 202
An Update on the Role of Serotonin and its Interplay with Dopamine for Reward
Fischer, A. G., & Ullsperger, M. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00484 · Cited by 189
Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics
Farré, M., de la Torre, R., Mathúna, B. Ó., Roset, P. N., Peiró, A. M., Torrens, M., Ortuño, J., Pujadas, M., & Camı́, J. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1789-7 · Cited by 165
The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals
Kamilar-Britt, P., & Bedi, G. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.08.016 · Cited by 163
Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
Wagner, M. T., Mithoefer, M. C., Mithoefer, A. T., MacAulay, R. K., Jerome, L., Yazar-Klosinski, B., & Doblin, R. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117711712 · Cited by 160
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
Dumont, G. J. H., & Verkes, R. J. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106063271 · Cited by 149
Safety pharmacology of acute MDMA administration in healthy subjects
Vizeli, P., & Liechti, M. E. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691569 · Cited by 157
The role of human drug self-administration procedures in the development of medications
Comer, S. D., Ashworth, J., Foltin, R. W., Johanson, C. E., Zacny, J. P., & WALSH, S. L. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.03.001 · Cited by 145
Self-citation
Effects of MDMA and intranasal oxytocin on social and emotional processing
Kirkpatrick, M. G., Lee, R., Wardle, M. C., Jacob, S., & de Wit, H. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.12 · Cited by 143
Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Freedman, R. R., Johanson, C., & Tancer, M. E. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0149-6 · Cited by 129
Self-citation
A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans
Kirkpatrick, M. G., Gunderson, E. W., Perez, A. Y., Haney, M., Foltin, R. W., & Hart, C. L. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2383-4 · Cited by 120
Direct comparison of the acute subjective, emotional, autonomic, and endocrine effects of MDMA, methylphenidate, and modafinil in healthy subjects
Dolder, P. C., Müller, F., Schmid, Y., Borgwardt, S. J., & Liechti, M. E. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4650-5 · Cited by 117
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy
Sumnall, H. R., Cole, J. C., & Jerome, L. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106060764 · Cited by 116
The effects of fluoxetine on the subjective and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans
Tancer, M., & Johanson, C.-E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0576-z · Cited by 113
Self-citation
Methylone and mCPP, two new drugs of abuse?
Bossong, M. G., Dijk, J. V., & Niesink, R. J. M. (2005) · Addiction Biology · doi:10.1080/13556210500350794 · Cited by 112
Plasma oxytocin concentrations following MDMA or intranasal oxytocin in humans
Kirkpatrick, M. G., Francis, S. M., Lee, R., de Wit, H., & Jacob, S. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.04.006 · Cited by 106
The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants
Bershad, A. K., Miller, M. A., Baggott, M. J., & de Wit, H. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116663120 · Cited by 106
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine
Steinkellner, T., Freissmuth, M., Sitte, H. H., & Montgomery, T. (2011) · Biological Chemistry · doi:10.1515/bc.2011.016 · Cited by 106
Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives
Simmler, L. D., Rickli, A., Schramm, Y., Hoener, M. C., & Liechti, M. E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.024 · Cited by 108
Experimental manipulations of behavioral economic demand for addictive commodities: a meta‐analysis
Acuff, S. F., Amlung, M. T., Dennhardt, A. A., MacKillop, J. M., & Murphy, J. G. (2019) · Addiction · doi:10.1111/add.14865 · Cited by 105
High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens
Reissig, C. J., Carter, L. P., Johnson, M. W., Mintzer, M. Z., Klinedinst, M. A., & Griffiths, R. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2680-6 · Cited by 91
Acute Chlorophenylpiperazine Overdose: A Case Report and Review of the Literature
Kovaleva, J., Devuyst, E., Paepe, P. D., & Verstraete, A. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318170a879 · Cited by 88
Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers
Zacny, J. P., & Lichtor, S. A. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0937-2 · Cited by 87
Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users
Brunt, T. M., Koeter, M. W. J., Niesink, R. J. M., & van den Brink, W. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2529-4 · Cited by 91
Determining the subjective and physiological effects of BZP on human females
Lin, J. C., Bangs, N., Lee, H., Kydd, R. R., & Russell, B. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1669-2 · Cited by 82
MDMA: Interactions with other psychoactive drugs
Mohamed, W. M. Y., Hamida, S. B., Cassel, J., de Vasconcelos, A. P., & Jones, B. C. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.032 · Cited by 77
MDMA effects consistent across laboratories
Kirkpatrick, M. G., Baggott, M. J., Mendelson, J. E., Galloway, G. P., Liechti, M. E., Hysek, C. M., & de Wit, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3528-z · Cited by 78
Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model*
Sprague, J. E., Moze, P., Caden, D., Rusyniak, D. E., Holmes, C. S., Goldstein, D. S., & Mills, E. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000165969.29002.70 · Cited by 73
Determining the subjective effects of TFMPP in human males
Jan, R. K., Lin, J. C., Lee, H., Sheridan, J. L., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1911-y · Cited by 72
Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination
Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2011) · Drug Testing and Analysis · doi:10.1002/dta.285 · Cited by 70
Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics
Luethi, D., & Liechti, M. E. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy047 · Cited by 70
Estimating the relative reinforcing strength of (±)-3,4-methylenedioxymethamphetamine (MDMA) and its isomers in rhesus monkeys: comparison to (+)-methamphetamine
Wang, Z., & Woolverton, W. L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0599-5 · Cited by 66
Perspectives on Zebrafish Models of Hallucinogenic Drugs and Related Psychotropic Compounds
Neelkantan, N., Mikhaylova, A., Stewart, A., Arnold, R., Gjeloshi, V., Kondaveeti, D., Poudel, M. K., & Kalueff, A. V. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400090q · Cited by 67
Effects of MDMA on body temperature in humans
Liechti, M. E. (2014) · Temperature · doi:10.4161/23328940.2014.955433 · Cited by 69
Intimate insight: MDMA changes how people talk about significant others
Baggott, M. J., Kirkpatrick, M. G., Bedi, G., & de Wit, H. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115581962 · Cited by 69
mCPP: an undesired addition to the ecstasy market
Bossong, M. G., Brunt, T. M., Dijk, J. V., Rigter, S., Hoek, J., Goldschmidt, H. M. J., & Niesink, R. J. M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109102541 · Cited by 63
Self-Administration of Intravenous Nicotine in Male and Female Cigarette Smokers
Sofuoglu, M., Yoo, S., Hill, K. P., & Mooney, M. E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301460 · Cited by 63
A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) with cocaine in rhesus monkeys
Lile, J. A., Ross, J. T., & Nader, M. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.10.006 · Cited by 64
Human behavioral pharmacology, past, present, and future: symposium presented at the 50th annual meeting of the Behavioral Pharmacology Society
Comer, S. D., Bickel, W. K., Yi, R., de Wit, H., Higgins, S. T., Wenger, G. R., Johanson, C., & Kreek, M. J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833bb9f8 · Cited by 60
Self-citation
An investigation of the subjective experiences of sex after alcohol or drug intoxication
Sumnall, H. R., Beynon, C. M., Conchie, S. M., Riley, S. C. E., & Cole, J. C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106075590 · Cited by 60
Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo
Johanson, C.-E., Kilbey, M., Gatchalian, K., & Tancer, M. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.05.003 · Cited by 58
Self-citation
Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers
Zacny, J. P., & Gutiérrez, S. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2008.11.013 · Cited by 56
MDMA-like behavioral effects of N-substituted piperazines in the mouse
Yarosh, H. L., KATZ, E., Coop, A., & Fantegrossi, W. E. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.06.007 · Cited by 53
Methylenedioxymethamphetamine (MDMA) in Psychiatry
Schenk, S., & Newcombe, D. A. L. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000962 · Cited by 53
Acute Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate on Circulating Steroid Levels in Healthy Subjects
Seibert, J., Hysek, C. M., Penno, C. A., Schmid, Y., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2014) · Neuroendocrinology · doi:10.1159/000364879 · Cited by 52
Methylenedioxymethamphetamine (MDMA): Serotonergic and dopaminergic mechanisms related to its use and misuse
Schenk, S., & Highgate, Q. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15348 · Cited by 48
Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens: Psychometrics of Three Psychedelic Rating Scales
Bouso, J. C., Pedrero-Pérez, E. J., Gandy, S., & Alcázar-Córcoles, M. Á. (2016) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2545 · Cited by 48
Neural and Cardiac Toxicities Associated With 3,4-Methylenedioxymethamphetamine (MDMA)
Baumann, M. H., & Rothman, R. B. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)88010-0 · Cited by 47
The association of ecstasy use and academic achievement among adolescents in two U.S. national surveys
Martins, S. S., & Alexandre, P. K. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2008.07.022 · Cited by 48
MDMA (“ecstasy”) abuse as an example of dopamine neuroplasticity
Schenk, S. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.12.010 · Cited by 43
Endocrine and Neurochemical Effects of 3,4-Methylenedioxymethamphetamine and Its Stereoisomers in Rhesus Monkeys
Murnane, K. S., Fantegrossi, W. E., Godfrey, J. R., Banks, M. L., & Howell, L. L. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.166595 · Cited by 43
MDMA: a social drug in a social context
Kirkpatrick, M. G., & de Wit, H. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3752-6 · Cited by 48
(±)-MDMA and its enantiomers: potential therapeutic advantages of R(−)-MDMA
Pitts, E. G., Curry, D. W., Hampshire, K. N., Young, M. B., & Howell, L. L. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4812-5 · Cited by 41
1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT2A receptors: Proposal of a modified rodent antidepressant assay
Rajkumar, R., Pandey, D. K., Mahesh, R., & Radha, R. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.02.041 · Cited by 41
MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
Parrott, A. C., Gibbs, A., Scholey, A. B., King, R., Owens, K., Swann, P., Ogden, E., & Stough, C. K. K. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2184-9 · Cited by 40
Considering the context: social factors in responses to drugs in humans
de Wit, H., & Sayette, M. A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4854-3 · Cited by 42
Can MDMA Play a Role in the Treatment of Substance Abuse?
Jerome, L., Schuster, S., & Yazar‐Klosinski, B. (2013) · Current Drug Abuse Reviews · doi:10.2174/18744737112059990005 · Cited by 39
Determining the subjective and physiological effects of BZP combined with TFMPP in human males
Lin, J. C., Jan, R. K., Lee, H., Jensen, M., Kydd, R. R., & Russell, B. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2081-7 · Cited by 37
A Fatality Following Ingestion of the Designer Drug Meta‐Chlorophenylpiperazine ( mCPP ) in an Asthmatic— HPLC‐MS/MS Detection in Biofluids and Hair
Gaillard, Y., Cuquel, A.-C., Boucher, A., Romeuf, L., Bévalot, F., Prevosto, J., & Menard, J. (2012) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2012.02254.x · Cited by 36
Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech
Marrone, G. F., Pardo, J. S., Krauss, R. M., & Hart, C. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1715-0 · Cited by 33
Naltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder
Roche, D. J. O., Worley, M. J., Courtney, K. E., Bujarski, S., London, E. D., SHOPTAW, S. J., & Ray, L. A. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4607-8 · Cited by 32
Social Cognition
Patin, A., & Hurlemann, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_10 · Cited by 37
Simultaneous Separation of Different Types of Amphetamine and Piperazine Designer Drugs by Capillary Electrophoresis with a Chiral Selector
Bishop, S., McCord, B. R., Gratz, S. R., Loeliger, J., & Witkowski, M. R. (2005) · Journal of Forensic Sciences · doi:10.1520/jfs2004239 · Cited by 32
The renaissance in psychedelic research: What do preclinical models have to offer
Murnane, K. S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.003 · Cited by 35
Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD
Lewis, C. R., Tafur, J., Spencer, S., Green, J. M., Harrison, C., Kelmendi, B., Rabin, D. M., Yehuda, R., Yazar‐Klosinski, B., & Cahn, B. R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.959590 · Cited by 32
Trazodone: properties and utility in multiple disorders
Mittur, A. V. (2011) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.138 · Cited by 30
Stimulants, ecstasy, and other ‘party drugs’
WINSTOCK, A. R., & Flechais, R. (2020) · doi:10.1093/med/9780198713005.003.0053 · Cited by 29
Effects of ecstasy on cooperative behaviour and perception of trustworthiness: A naturalistic study
Stewart, L. H., Ferguson, B., Morgan, C. J. A., Swaboda, N., Jones, L., Fenton, R., Wall, M. B., & Curran, H. V. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114544775 · Cited by 32
Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users?
Martins, S. S., Storr, C. L., Alexandre, P. K., & Chilcoat, H. D. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.10.006 · Cited by 30
Additive effects of 3,4-methylenedioxymethamphetamine (MDMA) and compassionate imagery on self-compassion in recreational users of ecstasy
Kamboj, S. K., Walldén, Y. S. E., Falconer, C. J., Alotaibi, M. R., Blagbrough, I. S., Husbands, S. M., & Freeman, T. P. (2018) · Mindfulness · doi:10.1007/s12671-017-0849-0 · Cited by 28
Co-administration of THC and MDMA (‘Ecstasy’) Synergistically Disrupts Memory in Rats
Young, J. M., McGregor, I. S., & Mallet, P. E. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300692 · Cited by 28
New psychoactive substances—Synthetic stimulants
Varı̀, M. R., Pichini, S., Giorgetti, R., & Busardò, F. P. (2018) · Wiley Interdisciplinary Reviews Forensic Science · doi:10.1002/wfs2.1197 · Cited by 26
Methamphetamine, amphetamine, and aggression in humans: A systematic review of drug administration studies
O’Malley, K. Y., Hart, C. L., Casey, S., & Downey, L. A. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104805 · Cited by 24
Behavioral and neurochemical effects of repeated MDMA administration during late adolescence in the rat
Cox, B. M., Shah, M. M., Cichon, T., Tancer, M. E., Galloway, M. P., Thomas, D. M., & Perrine, S. A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.021 · Cited by 22
Self-citation
Recent-onset ecstasy use: Association with deviant behaviors and psychiatric comorbidity.
Martins, S. S., Mazzotti, G., & Chilcoat, H. D. (2006) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.14.3.275 · Cited by 20
Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis
Regan, A., Margolis, S., de Wit, H., & Lyubomirsky, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258849 · Cited by 21
Reinstatement of extinguished amphetamine self-administration by 3,4-methylenedioxymethamphetamine (MDMA) and its enantiomers in rhesus monkeys
McClung, J. C., Fantegrossi, W. E., & Howell, L. L. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1818-7 · Cited by 19
Differential Substitution for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate in Rats
Mori, T., Uzawa, N., Kazawa, H., Watanabe, H., Mochizuki, A., Shibasaki, M., Yoshizawa, K., Higashiyama, K., & Suzuki, T. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214288 · Cited by 18
Perceived risk associated with ecstasy use: A latent class analysis approach
Martins, S. S., Carlson, R. G., Alexandre, P. K., & Falck, R. S. (2011) · Addictive Behaviors · doi:10.1016/j.addbeh.2011.01.013 · Cited by 21
Effects of lisdexamfetamine on plasma steroid concentrations compared with d-amphetamine in healthy subjects: A randomized, double-blind, placebo-controlled study
Strajhar, P., Vizeli, P., Patt, M., Dolder, P. C., Kratschmar, D. V., Liechti, M. E., & Odermatt, A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.10.016 · Cited by 17
Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates
Fantegrossi, W. E., Bauzo, R. M., Manvich, D. F., Morales, J. C. R., Votaw, J. R., Goodman, M. M., & Howell, L. L. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1545-0 · Cited by 17
Serotonin antagonists fail to alter MDMA self-administration in rats
Schenk, S., Foote, J., Aronsen, D., Bukholt, N., Highgate, Q., van de Wetering, R., & Webster, J. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.06.002 · Cited by 16
The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo
Murnane, K. S., Güner, O. F., Bowen, J. P., Rambacher, K. M., Moniri, N. H., Murphy, T. J., Daphney, C. M., Oppong‐Damoah, A., & Rice, K. C. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.04.003 · Cited by 16
Altered States and Social Bonds: Effects of MDMA and Serotonergic Psychedelics on Social Behavior as a Mechanism Underlying Substance-Assisted Therapy
Schmid, Y., & Bershad, A. K. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.02.001 · Cited by 15
Role of Serotonin Transporter and Receptor Gene Variations in the Acute Effects of MDMA in Healthy Subjects
Vizeli, P., zu Schwabedissen, H. E. M., & Liechti, M. E. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00590 · Cited by 13
Relationship between oral D-amphetamine self-administration and ratings of subjective effects
Bolin, B. L., Reynolds, A. R., Stoops, W. W., & Rush, C. R. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283645047 · Cited by 13
Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia
Bershad, A. K., & de Wit, H. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad094 · Cited by 12
A First-in-Man Study with 4-Fluoroamphetamine Demonstrates it Produces a Mild Psychedelic State
Kuypers, K. P. C., Perna, E. B. D. S. F., Theunissen, E. L., Toennes, S. W., Mason, N. L., Hutten, N. R. P. W., & Ramaekers, J. G. (2019) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2019.1569286 · Cited by 13
Emerging Designer Drugs
Nichols, D. E., & Fantegrossi, W. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00019-8 · Cited by 12
1-Benzylpiperazine and other Piperazine-based Derivatives
Gee, P., & Schep, L. J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415816-0.00008-0 · Cited by 11
Prior Activation of 5-HT7 Receptors Modulates the Conditioned Place Preference With Methylphenidate
Carbone, C., Russo, S. L. M. L., Lacivita, E., Frank, A., Alleva, E., Stark, H., Saso, L., Leopoldo, M., & Adriani, W. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00208 · Cited by 11

Authors: Tancer, M., & Johanson, C.-E.
Affiliations: Wayne State University (US)
Corresponding author: Tancer, Manuel
Venue: Drug and Alcohol Dependence
Publisher: Elsevier BV
Published: 2003-10
Volume: 72
Issue: 1
Pages: 33-44
ISSN: 0376-8716 (ISSN-L)
DOI: 10.1016/s0376-8716(03)00172-8
OpenAlex: W2127854642
Cited by: 153
References: 58
Citations by year: 2026: 1 · 2025: 1 · 2024: 5 · 2023: 2 · 2022: 1 · 2021: 8 · 2020: 3 · 2019: 6 · 2018: 12 · 2017: 8 · 2016: 7 · 2015: 5 · 2014: 13 · 2013: 7 · 2012: 10
FWCI: 8.16
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Drug and Alcohol Dependence (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k08da000370-05)
National Institute on Drug Abuse (5 K08 DA00370)
Topics: Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Keywords: MDMA, 3,4-methylenedioxymethamphetamine, d-amphetamine, mCPP, serotonin release, dopamine release, drug reinforcement, subjective effects, physiological effects, dose dependence
MeSH terms: Adolescent, Adult, Affect, Dextroamphetamine, Female, Hallucinogens, Humans, Hydrocortisone, Male, Piperazines, Surveys and Questionnaires, Reinforcement, Psychology, Severity of Illness Index, Serotonin Receptor Agonists, Dopamine Agonists, Cross-Over Studies, N-Methyl-3,4-methylenedioxyamphetamine, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks